| EN | ES
National Node of the BCH
Actividades, proyectos y oportunidades de creación de capacidad
Solicitud de información y estado
Identificación del registro
7065
Situación
Publicado
Fecha de creación
2004-11-15 15:46 UTC (sarah.lukie@croplife.org)
Fecha de la última actualización
2010-01-18 14:39 UTC (intern.ross.carroll@cbd.int)
Date of publication
2010-01-18 14:39 UTC (intern.ross.carroll@cbd.int)

Este documento también está disponible en los siguientes idiomas:
Información general
Tipo de iniciativa
EN
Capacity-Building Efforts of Individual Biotechnology Companies
País(es) beneficiario(s)
  • Chile
  • India
  • Indonesia
  • Kenya
  • Malasia
  • México
  • Filipinas
  • Tailandia
  • Viet Nam
  • Mundial
Tipo de iniciativa
Grupo principal de destinatario(s) / beneficiarios
  • Target group: Developing countries and countries with economies in transition.
Fecha de inicio
2004-01-01
Fecha de finalización
2004-12-31
Donante(s) de información
Agencia(s) u organización(es) que aplican o apoyan la iniciativa (Información suplementaria)
  • Organization: Global Industry Coalition
  • Type of Organization: Industry
Información presupuestaria
EN
Individual companies
International research organizations
Private foundations
Bilateral development cooperation agencies
Disponibilidad de fondos para los participantes
Yes
Detalles de la actividad
Descripción de la iniciativa
EN
Many individual companies are undertaking different activities in support of biosafety and research, development, transfer and use of biotechnologies in developing countries and countries with economies in transition.  

An example is the Novartis biosafety programme, which has as its purpose to minimize the potential hazards in the handling of biological materials. The company has worked with research institutions in such countries as Indonesia, Philippines, Thailand and Viet Nam to develop their capacities in biotechnology, including specifically on regulatory aspects of field trials, product development and distribution. It is planning to fund a pilot biosafety programme for a selected country in Africa, to be used as a model for other countries.

An other example is Monsanto, which is working with selected research institutions in developing countries to develop biotechnology research capacity related to specific types of LMO products, with companion capacity-building activities in risk assessment and LMO regulation. This has involved work in Kenya, Mexico, Indonesia, Philippines, Thailand, Malaysia and Viet Nam.
Objetivo, principales resultados esperados o lección aprendida
EN
Goals
To support research, development, transfer and use of biotechnologies in developing countries and countries with economies in transition.
To minimize the potential hazards in the hadling of biological materials.
To develop capacity-building activities in risk assessment and LMO regulation.
To develop national capacities in biotechnology, including regulatory aspects of field trials, product development and distribution.

Objectives
To develop awareness and capacities for biosafety in developing countries and countries with economies in transition.
Zonas(s) temática(s) generales
  • Capacitación institucional
  • Desarrollo y la formación en capacitación de recursos humanos
  • Intercambio de información y gestión de datos, incluida la participación en el CIISB
Información suplementaria
Información suplementaria
EN
Other collaborating organizations
Developing country research institutions, regulatory officials, biotechnology industry
OECD country universities
Agribiotechnologia de Costa Rica
AgrEvo GmbH
ANPROS (Chile)
Asgrow Seed
Cargill
Dupont
ELM/Seminis
Monsanto
Mitsubishi Chemicals
Novartis
Pioneer Hi-Bred International
ProAgro (India)
Schering and Zeneca Plant Sciences
ICI